NASHUA, NH, and SAN ANTONIO (Booth #423) Oct. 19, 2015 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, will present updated clinical data, host in-booth clinician presentations and showcase the latest in radiation technology at the American Society for Radiation Oncology (ASTRO) meeting in San Antonio, TX from October 18-21, 2015.
“ASTRO 2015 represents an important milestone where researchers are sharing the most recent, and longest-term data available supporting the use of the Xoft System for the treatment of both early-stage breast cancer and nonmelanoma skin cancer (NMSC),” said Ken Ferry, CEO of iCAD. “iCAD is committed to remaining at the forefront of innovation and research, and we look forward to sharing with our colleagues new data showing the advantages of the Xoft System for the treatment of an even wider variety of cancers.”
At the meeting, Dr. Ajay Bhatnagar and Dr. Parag Sanghvi will present posters with updated data on the use of eBx in the treatment of NMSC. Their data reflect treatment with the Xoft System for a total of 342 patients with 466 NMSC lesions, resulting in excellent cosmesis and few recurrences, with a mean follow up time of 16.5 months and 11.8 months, respectively.

Ad Statistics
Times Displayed: 50195
Times Visited: 1423 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Dr. Alam M. Nisar Syed and Dr. Adam Dickler will also present posters with data supporting use of the Xoft System for the treatment of early-stage breast cancer. Their data reflect treatment of 136 breast cancer lesions with the Xoft System, showing positive clinical results, excellent to good cosmesis, few recurrences, and a low rate of low-grade adverse events.
Posters will be presented in Poster Hall A from 10 am to 5 pm throughout the meeting; the Poster Viewing Reception will be from 5:30 pm to 6:45 pm on Monday, October 19.
- Electronic brachytherapy for the treatment of Non-Melanoma Skin Cancer: Results up to 5 years
Poster # 3598
Ajay Bhatnagar, MD, MBA, Medical Director, 21st Century Oncology of Arizona, Adjunct Assistant Professor of Radiation Oncology, University of Pittsburgh School of Medicine
- Clinical and Cosmetic Outcomes in Patients Treated With High Dose Rate Electronic Brachytherapy for Nonmelanoma Skin Cancer
Poster #3589
Parag Sanghvi, MD, MSPH, Assistant Professor, Radiation Oncology, University of California San Diego, San Diego, CA
- Feasibility and Early Outcomes of a Multi-Center Trial of Intra-Operative Radiation Therapy Using Electronic Brachytherapy at the Time of Breast Conservation Surgery for Early Stage Breast Cancer